Drug Trial Radar · NCT06072482
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
300
Planned (sponsor's estimate)
Start
Feb 7, 2024
Primary completion
Dec 31, 2036
Study completion Dec 31, 2036
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Oct 10, 2023
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate the long-term safety of avacopan in participants with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
Conditions
- Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Interventions
AvacopanDrug
Administered orally.
PlaceboDrug
Administered orally.
Standard of CareDrug
All participants will receive SoC background immunosuppressive therapy for induction and maintenance, at the discretion of the Investigator and as supported by current guidelines, product labels and local practices and informed by the individual participant's clinical condition, preferences, and values.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Experiencing Treatment-emergent Adverse Events (TEAEs)Time frame: Up to Month 60
- Percentage of Participants Experiencing Adverse Events of Special InterestTime frame: Up to Month 60
- Percentage of Participants Experiencing Serious Adverse EventsTime frame: Up to Month 60
- Percentage of Participants Experiencing Adverse Events Leading to WithdrawalTime frame: Up to Month 60
- Percentage of Participants Experiencing Adverse Events Leading to DeathTime frame: Up to Month 60
- Number of Participants Experiencing Clinical Significant Changes from Baseline in Vital Signs MeasurementsTime frame: Up to Month 60
- Number of Participants Experiencing Clinical Significant Changes from Baseline in Hematology AssessmentsTime frame: Up to Month 60
- Number of Participants Experiencing Clinical Significant Changes from Baseline in Serum Chemistry AssessmentsTime frame: Up to Month 60
- Number of Participants Experiencing Clinical Significant Changes from Baseline in Urinalysis AssessmentsTime frame: Up to Month 60
Locations
82 sites in 7 countries. Site status is shown where the registry gives one.
Orthopedic Physicians Alaska
Anchorage, Alaska · Terminated
Scottsdale Healthcare at Shea - HonorHealth
Scottsdale, Arizona · Recruiting
Southwest Kidney Institute
Surprise, Arizona · Recruiting
Unity Health
Searcy, Arkansas · Recruiting
Medvin Clinical Research
Covina, California · Terminated
Palo Alto Medical Foundation Fremont
Fremont, California · Recruiting
The Nephrology Group
Fresno, California · Recruiting
Providence Medical Foundation
Fullerton, California · Recruiting
Southland Arthritis and Osteoarthritis Medical Center, Inc
Menifee, California · Recruiting
University of California San Francisco- Zuckerburg San Francisco General
San Francisco, California · Recruiting
Harbor University of California at Los Angeles Medical Center
Torrance, California · Recruiting
Amicis Research Center
Valencia, California · Recruiting
University of Colorado
Aurora, Colorado · Recruiting
Florida Kidney Physicians
Boca Raton, Florida · Recruiting
Malcom Randall Veterans Affairs Medical Center
Gainesville, Florida · Recruiting
Mayo Clinic
Jacksonville, Florida · Recruiting
ClinTrial Research Oakwater, Llc
Orlando, Florida · Recruiting
University of South Florida
Tampa, Florida · Recruiting
Emory University
Atlanta, Georgia · Recruiting
Lake Cumberland Rheumatology
New Albany, Indiana · Recruiting
University of Iowa Hospitals and Clinics
Iowa City, Iowa · Recruiting
University of Kentucky
Lexington, Kentucky · Recruiting
Johns Hopkins Bayview Medical Center
Baltimore, Maryland · Recruiting
Massachusetts General Hospital
Boston, Massachusetts · Recruiting
Brigham and Womens Hospital
Boston, Massachusetts · Terminated
Henry Ford Health System
Detroit, Michigan · Recruiting
Kidney Michigan Institute
Saginaw, Michigan · Recruiting
Clinical Research Institute of Michigan
Saint Clair Shores, Michigan · Recruiting
Revive Research Institute
Sterling Heights, Michigan · Recruiting
University of Minnesota
Minneapolis, Minnesota · Recruiting
Mayo Clinic
Rochester, Minnesota · Recruiting
Renown Rheumatology
Reno, Nevada · Recruiting
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire · Recruiting
Renal Medicine Associates
Albuquerque, New Mexico · Recruiting
New York Nephrology Vasculitis and Glomerular Center
Albany, New York · Recruiting
Northwell Health
Great Neck, New York · Recruiting
Hospital For Special Surgery
New York, New York · Recruiting
Carolina Kidney Associates
Greensboro, North Carolina · Recruiting
East Carolina University Brody Outpatient Center
Greenville, North Carolina · Recruiting
Brookview Hills Research Associates Llc
Winston-Salem, North Carolina · Recruiting
Showing 40 of 82 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.